These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 16854083

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [99mTc]Demotensin 5 and 6 in the NTS1-R-targeted imaging of tumours: synthesis and preclinical results.
    Maina T, Nikolopoulou A, Stathopoulou E, Galanis AS, Cordopatis P, Nock BA.
    Eur J Nucl Med Mol Imaging; 2007 Nov; 34(11):1804-14. PubMed ID: 17594090
    [Abstract] [Full Text] [Related]

  • 3. [99mTc]demotensin VI: biodistribution and initial clinical results in tumor patients of a pilot/phase I study.
    Gabriel M, Decristoforo C, Wöll E, Eisterer W, Nock B, Maina T, Moncayo R, Virgolini I.
    Cancer Biother Radiopharm; 2011 Oct; 26(5):557-63. PubMed ID: 21883013
    [Abstract] [Full Text] [Related]

  • 4. Novel bioactive and stable neurotensin peptide analogues capable of delivering radiopharmaceuticals and molecular beacons to tumors.
    Achilefu S, Srinivasan A, Schmidt MA, Jimenez HN, Bugaj JE, Erion JL.
    J Med Chem; 2003 Jul 17; 46(15):3403-11. PubMed ID: 12852770
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Radiolabeled neurotensin analog, 99mTc-NT-XI, evaluated in ductal pancreatic adenocarcinoma patients.
    Buchegger F, Bonvin F, Kosinski M, Schaffland AO, Prior J, Reubi JC, Bläuenstein P, Tourwé D, García Garayoa E, Bischof Delaloye A.
    J Nucl Med; 2003 Oct 17; 44(10):1649-54. PubMed ID: 14530481
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Catabolism of neurotensins. Implications for the design of radiolabeling strategies of peptides.
    Schubiger PA, Allemann-Tannahill L, Egli A, Schibli R, Alberto R, Carrel-Rémy N, Willmann M, Bläuenstein P, Tourwé D.
    Q J Nucl Med; 1999 Jun 17; 43(2):155-8. PubMed ID: 10429510
    [Abstract] [Full Text] [Related]

  • 10. Novel neurotensin analogues for radioisotope targeting to neurotensin receptor-positive tumors.
    Alshoukr F, Rosant C, Maes V, Abdelhak J, Raguin O, Burg S, Sarda L, Barbet J, Tourwé D, Pelaprat D, Gruaz-Guyon A.
    Bioconjug Chem; 2009 Aug 19; 20(8):1602-10. PubMed ID: 19610615
    [Abstract] [Full Text] [Related]

  • 11. Preclinical evaluation of a new, stabilized neurotensin(8--13) pseudopeptide radiolabeled with (99m)tc.
    García-Garayoa E, Bläuenstein P, Bruehlmeier M, Blanc A, Iterbeke K, Conrath P, Tourwé D, Schubiger PA.
    J Nucl Med; 2002 Mar 19; 43(3):374-83. PubMed ID: 11884498
    [Abstract] [Full Text] [Related]

  • 12. Radionuclide imaging of small-cell lung cancer (SCLC) using 99mTc-labeled neurotensin peptide 8-13.
    Zhang K, An R, Gao Z, Zhang Y, Aruva MR.
    Nucl Med Biol; 2006 May 19; 33(4):505-12. PubMed ID: 16720242
    [Abstract] [Full Text] [Related]

  • 13. Optimizing the Profile of [99mTc]Tc-NT(7-13) Tracers in Pancreatic Cancer Models by Means of Protease Inhibitors.
    Kanellopoulos P, Nock BA, Krenning EP, Maina T.
    Int J Mol Sci; 2020 Oct 26; 21(21):. PubMed ID: 33114537
    [Abstract] [Full Text] [Related]

  • 14. In vitro and in vivo evaluation of new radiolabeled neurotensin(8-13) analogues with high affinity for NT1 receptors.
    García-Garayoa E, Allemann-Tannahill L, Bläuenstein P, Willmann M, Carrel-Rémy N, Tourwé D, Iterbeke K, Conrath P, Schubiger PA.
    Nucl Med Biol; 2001 Jan 26; 28(1):75-84. PubMed ID: 11182567
    [Abstract] [Full Text] [Related]

  • 15. New neurotensin analogue radiolabeled by 99m-technetium as a potential agent for tumor identification.
    Emrarian I, Sadeghzadeh N, Abedi SM, Abediankenari S.
    Chem Biol Drug Des; 2018 Jan 26; 91(1):304-313. PubMed ID: 28816013
    [Abstract] [Full Text] [Related]

  • 16. 99mTc-HYNIC-Gastrin Peptides: Assisted Coordination of 99mTc by Amino Acid Side Chains Results in Improved Performance Both In Vitro and In Vivo.
    King R, Surfraz MB, Finucane C, Biagini SC, Blower PJ, Mather SJ.
    J Nucl Med; 2009 Apr 26; 50(4):591-8. PubMed ID: 19289435
    [Abstract] [Full Text] [Related]

  • 17. CCK-2/gastrin receptor-targeted tumor imaging with (99m)Tc-labeled minigastrin analogs.
    Nock BA, Maina T, Béhé M, Nikolopoulou A, Gotthardt M, Schmitt JS, Behr TM, Mäcke HR.
    J Nucl Med; 2005 Oct 26; 46(10):1727-36. PubMed ID: 16204724
    [Abstract] [Full Text] [Related]

  • 18. Stabilization of neurotensin analogues: effect on peptide catabolism, biodistribution and tumor binding.
    Bruehlmeier M, Garayoa EG, Blanc A, Holzer B, Gergely S, Tourwé D, Schubiger PA, Bläuenstein P.
    Nucl Med Biol; 2002 Apr 26; 29(3):321-7. PubMed ID: 11929702
    [Abstract] [Full Text] [Related]

  • 19. Facile Preparation of a Thiol-Reactive (18)F-Labeling Agent and Synthesis of (18)F-DEG-VS-NT for PET Imaging of a Neurotensin Receptor-Positive Tumor.
    Wu Z, Li L, Liu S, Yakushijin F, Yakushijin K, Horne D, Conti PS, Li Z, Kandeel F, Shively JE.
    J Nucl Med; 2014 Jul 26; 55(7):1178-84. PubMed ID: 24854793
    [Abstract] [Full Text] [Related]

  • 20. Organometallic 99mTc(III) '4 + 1' bombesin(7-14) conjugates: synthesis, radiolabeling, and in vitro/in vivo studies.
    Kunstler JU, Veerendra B, Figueroa SD, Sieckman GL, Rold TL, Hoffman TJ, Smith CJ, Pietzsch HJ.
    Bioconjug Chem; 2007 Jul 26; 18(5):1651-61. PubMed ID: 17663527
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.